Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0Ourém mutation: A clinical characterization

L. Vaz-Rodrigues, F. Costa, S. Seixas, J. Rocha, C. Mendonça (Coimbra, Portugal)

Source: Annual Congress 2010 - Genetics of obstruction
Session: Genetics of obstruction
Session type: Thematic Poster Session
Number: 1570
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Vaz-Rodrigues, F. Costa, S. Seixas, J. Rocha, C. Mendonça (Coimbra, Portugal). Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0Ourém mutation: A clinical characterization. Eur Respir J 2010; 36: Suppl. 54, 1570

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tracing down the evolutionary history of Q0Ourém, a rare allele associated with severe alpha-1-antitrypsin deficiency (AATD)
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009


Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD.
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ)
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006

Aα360: A measure of disease and treatment efficacy in alpha-1-antitrypsin (A1AT) deficiency
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010

Erythrocyte abnormalities in alpha-1-antitrypsin deficiency (AATD) patients
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009

Characterization of a population of alpha1-antitrypsin deficient (A1ATD) patients
Source: Annual Congress 2008 - COPD
Year: 2008


Incidence of alpha-1-antitrypsin (α1-AT) deficiency in patients with COPD in Poland, preliminary report
Source: Eur Respir J 2005; 26: Suppl. 49, 440s
Year: 2005

Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe dyspnea
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016


A new SERPINA-1 missense mutation associated with alpha-1 antitrypsin deficiency and bronchiectasis.
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017


Prevalence and phenotype of subjects carrying rare variants in Argentina for alpha1-antitrypsin deficiency
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017


Rare SERPINA1 allele Mwhitstable in patients with Alpha1-antitrypsin deficiency
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019


Young adult with inherited PiMZ alpha-1-antitrypsin deficiency (A1ATD)-related bronchiectasis: characteristic of blood neutrophils and A1AT protein
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016


The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Preliminary results from newborn screening
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012


Mortality of patients with emphysema and alpha-1-antitrypsin deficiency of Pi Z phenotype
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001

Health status changes in alpha-1-antitrypsin deficiency (PiZ phenotype) over 3 years
Source: Annual Congress 2003 - Alpha-1 antitrypsin deficiency and COPD
Year: 2003


MiR-320c regulates SERPINA1 expression and is associated with pulmonary disease in alpha-1-antitrypsin deficiency
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

a1-antitrypsin PI*SZ genotype: a SERPINA1 deficiency haplotype with uncertain clinical and therapeutic implications
Source: Eur Respir J, 55 (6) 2000713; 10.1183/13993003.00713-2020
Year: 2020



Investigating change in the COPD assessment test (CAT) within α-1 antitrypsin deficiency (A1ATD)
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011


Role of bronchiectasis in alpha1-antitrypsin deficiency patients: a comparative analysis
Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Year: 2019